Contact
searchSearch
HMP Global

FDA News News

News
Blood Pressure Injections Recalled
05/26/2023
Jolynn Tumolo
Several thousand products containing phenylephrine and norepinephrine were recalled due to a lack of sterility assurance.
Several thousand products containing phenylephrine and norepinephrine were recalled due to a lack of sterility assurance.
Several thousand products...
05/26/2023
Pharmacy Learning Network
News
Astral SteriTech Recalls 5 Injections Manufactured for 4 US Clients
05/26/2023
Jolynn Tumolo
The recalls, designated Class II by the US Food and Drug Administration, impact a variety of antibiotic injections.
The recalls, designated Class II by the US Food and Drug Administration, impact a variety of antibiotic injections.
The recalls, designated Class II...
05/26/2023
Pharmacy Learning Network
News
Two Firms Recall Statins
04/14/2023
Jolynn Tumolo
Class II recalls have been issued for multiple statins manufactured by two firms and distributed throughout the United States.
Class II recalls have been issued for multiple statins manufactured by two firms and distributed throughout the United States.
Class II recalls have been...
04/14/2023
Pharmacy Learning Network
News
Asthma Med Recalled
04/14/2023
Jolynn Tumolo
Teva Pharmaceuticals is voluntarily recalling a prescription drug used to control asthma and relieve symptoms of allergic rhinitis.
Teva Pharmaceuticals is voluntarily recalling a prescription drug used to control asthma and relieve symptoms of allergic rhinitis.
Teva Pharmaceuticals is...
04/14/2023
Pharmacy Learning Network
News
Anxiety Drug Recalled
04/14/2023
Jolynn Tumolo
A prescription medication used to treat anxiety and panic disorder is under a Class II recall due to cross contamination concerns.
A prescription medication used to treat anxiety and panic disorder is under a Class II recall due to cross contamination concerns.
A prescription medication used...
04/14/2023
Pharmacy Learning Network
News
FDA Approves Factor VIII Replacement Therapy for Hemophilia A
03/09/2023
Maria Asimopoulos
Antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl, known by the branded name Altuviiio, is expected to hit the US market in April 2023.
Antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl, known by the branded name Altuviiio, is expected to hit the US market in April 2023.
Antihemophilic factor...
03/09/2023
First Report Managed Care
News
Class I Recall for Thyroid Medication
03/02/2023
Jolynn Tumolo
A prescription drug used to treat hypothyroidism is under a Class I recall because the medication may be subpotent.
A prescription drug used to treat hypothyroidism is under a Class I recall because the medication may be subpotent.
A prescription drug used to...
03/02/2023
Pharmacy Learning Network
News
Blood Thinner Recalled
03/02/2023
Jolynn Tumolo
More than 12,000 bottles of warfarin are being recalled for failing to meet testing specifications.
More than 12,000 bottles of warfarin are being recalled for failing to meet testing specifications.
More than 12,000 bottles of...
03/02/2023
Pharmacy Learning Network
News
Sanitizing Products Recalled
02/10/2023
Jolynn Tumolo
Several sanitizing and disinfecting products are under a Class II recall for deviations from Current Good Manufacturing Practices.
Several sanitizing and disinfecting products are under a Class II recall for deviations from Current Good Manufacturing Practices.
Several sanitizing and...
02/10/2023
Pharmacy Learning Network
News
Contaminated OTC Burn Cream Prompts Class I Recall
02/10/2023
Jolynn Tumolo
A Class I recall has been issued for burn cream due to microbial contamination.
A Class I recall has been issued for burn cream due to microbial contamination.
A Class I recall has been issued...
02/10/2023
Pharmacy Learning Network

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use